(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
5 days till quarter result
(bmo 2024-05-09)
Expected move: +/- 9.66%
0.00% $ 3.01
Live Chart Being Loaded With Signals
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally...
Stats | |
---|---|
Dzisiejszy wolumen | 21 130.00 |
Średni wolumen | 20 769.00 |
Kapitalizacja rynkowa | 16.76M |
EPS | $0 ( 2024-02-14 ) |
Następna data zysków | ( $-0.640 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.750 |
ATR14 | $0.0250 (0.83%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-31 | Pyszczymuka Greg | Buy | 208 | Common Shares |
2024-03-31 | Pyszczymuka Greg | Sell | 208 | Restricted Stock Units |
2023-12-31 | Pyszczymuka Greg | Buy | 209 | Common Shares |
2023-12-31 | Pyszczymuka Greg | Sell | 209 | Restricted Stock Units |
2023-09-30 | Pyszczymuka Greg | Buy | 208 | Common Shares |
INSIDER POWER |
---|
31.03 |
Last 94 transactions |
Buy: 33 552 785 | Sell: 39 056 468 |
Aytu BioScience Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
REYN | 0.959 |
SRNGW | 0.954 |
IBRX | 0.951 |
VWE | 0.949 |
HCAQ | 0.948 |
JAGX | 0.946 |
CHKEL | 0.945 |
PROC | 0.943 |
MAGS | 0.942 |
LGMK | 0.941 |
10 Najbardziej negatywne korelacje | |
---|---|
SMAP | -0.957 |
OVLY | -0.955 |
VAQC | -0.953 |
IPVIU | -0.948 |
SY | -0.948 |
GENQ | -0.948 |
ATEC | -0.946 |
HPLTU | -0.944 |
SJ | -0.943 |
IGTA | -0.943 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Aytu BioScience Inc Finanse
Annual | 2023 |
Przychody: | $107.40M |
Zysk brutto: | $66.63M (62.04 %) |
EPS: | $-5.11 |
FY | 2023 |
Przychody: | $107.40M |
Zysk brutto: | $66.63M (62.04 %) |
EPS: | $-5.11 |
FY | 2022 |
Przychody: | $96.67M |
Zysk brutto: | $52.28M (54.08 %) |
EPS: | $-1 499.10 |
FY | 2021 |
Przychody: | $65.63M |
Zysk brutto: | $29.20M (44.49 %) |
EPS: | $-0.174 |
Financial Reports:
No articles found.
Aytu BioScience Inc
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT for the treatment of ADHD in patients from 6 to 17 years old; and Adzenys ER, an oral suspension for the treatment of ADHD in patients from 6 years and older. It also provides Karbinal ER, a carbinoxamine oral suspension for the treatment of seasonal and perennial allergies; Poly-Vi-Flor and Tri-Vi-Flor prescription supplements for infants and children for the treatment of fluoride deficiency; Tuzistra XR, a prescription antitussive consisting of codeine polistirex and chlorpheniramine polistirex in an oral suspension; and ZolpiMist, an oral spray for the treatment of insomnia. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu Biopharma, Inc. in March 2021. Aytu Biopharma, Inc. was incorporated in 2015 and is headquartered in Englewood, Colorado.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej